E4D Compare Adapted to Preclinical Endodontics

August 21, 2024 updated by: Texas A&M University

E4D Compare Adapted to Evaluate Pulpal Access Cavity Preparation in the D2 Preclinical Endodontics Course: Educational Randomized Controlled Trial

Based on pilot study's promising results, we decided to further investigate the impact of adapting Planmeca Romexis Compare software to evaluate pulpal access preparations on second-year dental students' technical performance, self-evaluation skills and opinions. No educational records, grades, coursework, or any other assignments that are completed as part of the regular class will be analyzed as part of this study.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

59

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Second-year dental students enrolled in DDDS 719 Integrated Practice of Dentistry Lab II during 2022-2023 at Texas A&M School of Dentistry
  • Students who have completed fixed prosthodontics preclinical course
  • Students attending the endodontics preclinical course.

Exclusion Criteria:

  • First, third and fourth-year dental students at Texas A&M School of Dentistry
  • Second-year dental students NOT enrolled in DDDS 719 Integrated Practice of Dentistry Lab II during 2022-2023 at Texas A&M School of Dentistry
  • Students who are not interested in participating.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-assessment - traditional method vs traditional method plus 3D software method
Time Frame: baseline, 2 weeks, 4 weeks, 5 weeks and 7 weeks
Compare self-assessment after traditional method only and with extra 3D software method
baseline, 2 weeks, 4 weeks, 5 weeks and 7 weeks
Grading - traditional method vs traditional method plus 3D software method
Time Frame: baseline, 2 weeks, 4 weeks, 5 weeks and 7 weeks
Compare technical skills after traditional method only and with extra 3D software method
baseline, 2 weeks, 4 weeks, 5 weeks and 7 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Grading - traditional/visual grading vs 3D software grading
Time Frame: baseline, 2 weeks, 4 weeks, 5 weeks and 7 weeks
Compare traditional/visual grading to 3D software grading using different tolerance levels
baseline, 2 weeks, 4 weeks, 5 weeks and 7 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 27, 2023

Primary Completion (Actual)

May 8, 2023

Study Completion (Actual)

May 8, 2023

Study Registration Dates

First Submitted

August 19, 2024

First Submitted That Met QC Criteria

August 21, 2024

First Posted (Actual)

August 22, 2024

Study Record Updates

Last Update Posted (Actual)

August 22, 2024

Last Update Submitted That Met QC Criteria

August 21, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • IRB2022-1492-CD-EXM

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Self-Perception

Subscribe